//fpnotebook.com/
Sotalol
Aka: Sotalol, Betapace- Indication
- Ventricular Arrhythmia
- Supraventricular Arrhythmia
- Atrial Fibrillation Cardioversion
- Time to Cardioversion: 3-6 hours
- Conversion Rate: 20-52%
- Chronic Efficacy: 50-60%
- Atrial Fibrillation Cardioversion
- Mechanism
- Class III Antiarrhythmic
- Prolongs action potential duration
- Increases cardiac tissue refractoriness
- Class II Antiarrhythmic
- Non-selective Beta Blocker
- Class III Antiarrhythmic
- Adverse Effects
- Bradycardia
- Hypotension
- Proarrhythmia (Torsades de Pointes)
- Associated with doses over 320 mg per day
- Dosing: Oral
- Starting Dose: 80 mg PO bid
- Typical dosing: 80-160 mg PO bid
- Maximum: 640 mg per day
Medication Costs | ||
---|---|---|
Sotalol HCL (on 6/18/2017 at Walmart.com) | ||
Sotalol HCL 80mg | #30 tablets for $4.00 | $0.13 each |
Sotalol HCL 80mg | #90 tablets for $10.00 | $0.11 each |
sotalol (on 5/17/2017 at Medicaid.Gov Pharmacy Drug pricing) | ||
SOTALOL 120 MG TABLET | Generic | $0.14 each |
SOTALOL 160 MG TABLET | Generic | $0.16 each |
SOTALOL 80 MG TABLET | Generic | $0.09 each |
SOTALOL AF 120 MG TABLET | Generic | $0.14 each |
SOTALOL AF 160 MG TABLET | Generic | $0.16 each |
SOTALOL AF 80 MG TABLET | Generic | $0.09 each |
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information. |
Sotalol (C0037707) |
|
---|---|
Definition (NCI) | An ethanolamine derivative with Class III antiarrhythmic and antihypertensive properties. Sotalol is a nonselective beta-adrenergic receptor and potassium channel antagonist. In the heart, this agent inhibits chronotropic and inotropic effects thereby slowing the heart rate and decreasing myocardial contractility. This agent also reduces sinus rate, slows conduction in the atria and in the atrioventricular (AV) node and increases the functional refractory period of the AV node. |
Definition (MSH) | An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias. |
Concepts | Pharmacologic Substance (T121) , Organic Chemical (T109) |
MSH | D013015 |
SnomedCT | 372911006, 96301002 |
LNC | LP16279-9, MTHU003385 |
English | Sotalol, Methanesulfonamide, N-(4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)-, sotalol, Sotalol [Chemical/Ingredient], antiarrhythmics sotalol, sotalol (medication), SOTALOL, Sotalol (product), Sotalol (substance) |
Swedish | Sotalol |
Czech | sotalol |
Finnish | Sotaloli |
Russian | SOTALOL, СОТАЛОЛ |
Japanese | ソタロール |
Polish | Sotalol |
Spanish | sotalol (producto), sotalol (sustancia), sotalol, Sotalol |
French | Sotalol |
German | Sotalol |
Italian | Sotalolo |
Portuguese | Sotalol |
Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
Betapace (C0728751) |
|
---|---|
Concepts | Pharmacologic Substance (T121) , Organic Chemical (T109) |
English | Betapace, betapace |
Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.
If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.
Please Contact Me as you run across problems with any of these versions on the website.